NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Biorce

Biorce

Private
BarcelonaHealthcare & Life Scienceshttps://www.biorce.com/

Last Round

Series A

Feb 2, 2026

Total Funding Raised

$61.56M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Biorce is a healthcare technology company that provides an AI-native clinical intelligence platform designed to accelerate and optimize clinical trial design, protocol development, and regulatory planning for pharmaceutical and biotechnology organizations.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

drug discoveryclinical trial optimizationAI drug discoveryin silico drug discoverycomputational biologyAI pharmapredictive analyticsmulti-omicsAI clinical trialsclinical trial softwaredrug development platformbiotech AISaaSGxP complianceSOC 2

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biorce Comps

Public and private peers based on sector, stage, and business model.

Biorce comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Biorce Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 2, 2026
SeedJul 8, 2025
SeedNov 14, 2024

Key People

Founding team and executive leadership

Diogo Pisoeiro

Co-Founder Chief Product Officer

Founding Team

Michele Shipley

EA to Founder & CEO

Founding Team

Pedro Coelho

Founder CEO

Founding Team

Biorce Investors

Notable investors and investment history

Biorce investors
InvestorRounds
DST GlobalSeries A
Mustard Seed MazeSeries A, Seed
Plug and Play Tech CenterSeed
Outsized VenturesSeed
YZR CapitalSeries A, Seed
Outsized VenturesSeed
Norrsken VCSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    Grew 46% QoQ, from 102 to 149 employees.

  • Apr 18, 2026

    Developing a patient-facing app for clinical trial participants.

Biorce Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biorce Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biorce's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range149
Year Founded2024
Last FundingFeb 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.